Editorial: Perspective in current neuroprotection strategies
Neurosurg Focus
.
2017 Apr;42(4):E5.
doi: 10.3171/2017.1.FOCUS1728.
Authors
Hideo Okada
1
2
,
Yoshikazu Matsuda
1
3
,
Joonho Chung
1
4
5
,
R Webster Crowley
1
,
Demetrius K Lopes
1
Affiliations
1
Department of Neurological Surgery, Rush University Medical Center, Chicago, Illinois.
2
Department of Neurosurgery, Wakayama Rosai Hospital.
3
Department of Neurosurgery, Wakayama Medical University, Wakayama City, Japan.
4
Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; and.
5
Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
PMID:
28366072
DOI:
10.3171/2017.1.FOCUS1728
No abstract available
Publication types
Editorial
MeSH terms
Brain Ischemia / drug therapy*
Clinical Trials as Topic*
Humans
Neuroprotection / drug effects*
Neuroprotection / physiology
Neuroprotective Agents / therapeutic use*
Substances
Neuroprotective Agents